41241_2020_89_MOESM2_ESM.docx (161.39 kB)
Additional file 2 of Biomarker testing for advanced lung cancer by next-generation sequencing; a valid method to achieve a comprehensive glimpse at mutational landscape
journal contribution
posted on 2020-06-01, 03:21 authored by Anurag Mehta, Smreti Vasudevan, Sanjeev Kumar Sharma, Manoj Panigrahi, Moushumi Suryavanshi, Mumtaz Saifi, Ullas BatraAdditional file 2. Pattern and distribution of the TP53 mutations in the cohort according to (A) Mutation type (B) Mutation effect on TP53 protein sequence (C) Exon/ Intron distribution (D) Functional effect (E) SIFT prediction (IARC TP53 Database). (N = 100, lung cancer subjects).